Pharmacokinetics of Off Label Pediatric Medications
NCT01286519 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-05-31
Summary
The purpose of this study is to measure the level of medicines found in body fluids such as blood, urine, spinal fluid of children.
Conditions
- Off Label Use of Medications in Pediatric Patients
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Matthew M. Laughon, MD, MPH · University of North Carolina
Eligibility
- Min Age
- 1 Day
- Max Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2035-12-31
- Completion
- 2035-12-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetics of Ketamine in Infants and Children
NCT00553839 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
NCT01635101 ·Status: COMPLETED ·Phase: PHASE3
-
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
NCT00229671 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric
NCT03337581 ·Status: UNKNOWN ·Phase: PHASE4
-
Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children
NCT02852590 ·Status: COMPLETED
-
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients
NCT03145272 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants
NCT03059511 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months
NCT01378988 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Ketamine for Control of Chronic Pain in Children
NCT01369680 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Low Dose Ketamine Infusion
NCT00618397 ·Status: TERMINATED ·Phase: PHASE1
-
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
NCT02044497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Effect of General Anesthesia on Pharmacokinetics of Oxycodone in Pediatric
NCT03054831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures
NCT04897750 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates
NCT01557985 ·Status: COMPLETED
-
Opioid Laws and Pediatric Use
NCT04543227 ·Status: COMPLETED
-
Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL
NCT03485014 ·Status: COMPLETED ·Phase: PHASE1
-
Preventing Acute Kidney Injury (AKI) in Pediatric Patients
NCT03897335 ·Status: UNKNOWN ·Phase: PHASE3
-
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
NCT01206907 ·Status: WITHDRAWN ·Phase: PHASE3
-
Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old
NCT02221674 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT04278404 ·Status: RECRUITING
-
Phenylephrine Pediatric Pharmacokinetic Study
NCT00762567 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
NCT01192295 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
NCT02728128 ·Status: COMPLETED
-
Acetaminophen Dosing in Obese Adolescents
NCT03192566 ·Status: SUSPENDED ·Phase: PHASE3
-
Morphine PK Subgroup Analysis
NCT01322191 ·Status: COMPLETED ·Phase: PHASE4